Inventor
XIAO DENGMING
US42 patents
⚠️ This page may combine multiple inventors who share the name “XIAO DENGMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CV THERAPEUTICS INC
8 patentsUS6977300B2Dec 20, 2005
A2B adenosine receptor antagonists
CV THERAPEUTICS INC69 citations98
US6825349B2Nov 30, 2004
A2B adenosine receptor antagonists
CV THERAPEUTICS INC95 citations98
US7317017B2Jan 8, 2008
A2B adenosine receptor antagonists
CV THERAPEUTICS INC22 citations92
US7304070B2Dec 4, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC23 citations92
US7238700B2Jul 3, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC11 citations84
US7105665B2Sep 12, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC12 citations84
US7144871B2Dec 5, 2006
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC5 citations73
US7696181B2Apr 13, 2010
Partial and full agonists of A1 adenosine receptors
CV THERAPEUTICS INC1 citations51
MITCHELL IAN S
6 patentsUS8063050B2Nov 22, 2011
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S63 citations97
US8853199B2Oct 7, 2014
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S20 citations92
US8846681B2Sep 30, 2014
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MITCHELL IAN S11 citations83
US8329701B2Dec 11, 2012
Dihydrofuro pyrimidines as AKT protein kinase inhibitors
MITCHELL IAN S12 citations83
US8680114B2Mar 25, 2014
AKT protein kinase inhibitors
MITCHELL IAN S5 citations70
US9303040B2Apr 5, 2016
Substituted piperazines as AKT inhibitors
MITCHELL IAN S1 citations51
CENTAURUS BIOPHARMA CO LTD
6 patentsUS9926299B2Mar 27, 2018
Inhibitors of bruton's tyrosine kinase
CENTAURUS BIOPHARMA CO LTD33 citations91
US9309211B2Apr 12, 2016
Arylalkene derivatives and use thereof as selective estrogen receptor modulators
CENTAURUS BIOPHARMA CO LTD11 citations83
US9550781B2Jan 24, 2017
Kinase modulating compounds, compositions containing the same and use thereof
CENTAURUS BIOPHARMA CO LTD9 citations81
US10112922B2Oct 30, 2018
Inhibitor of bruton's tyrosine kinase
CENTAURUS BIOPHARMA CO LTD4 citations73
US10561657B2Feb 18, 2020
Pyrrolopyrimidine compound
CENTAURUS BIOPHARMA CO LTD3 citations71
US10155775B2Dec 18, 2018
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
CENTAURUS BIOPHARMA CO LTD0 citations51
ARRAY BIOPHARMA INC
5 patentsUS8003651B2Aug 23, 2011
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC35 citations92
US9359340B2Jun 7, 2016
Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors
ARRAY BIOPHARMA INC9 citations83
US8377937B2Feb 19, 2013
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC15 citations83
US9409886B2Aug 9, 2016
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
ARRAY BIOPHARMA INC2 citations61
US8846683B2Sep 30, 2014
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
ARRAY BIOPHARMA INC1 citations51
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
5 patentsUS9725439B2Aug 8, 2017
Quinazoline derivative and preparation method therefor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD13 citations83
US9708295B2Jul 18, 2017
Substituted 2-aminopyridine protein kinase inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3 citations71
US10385038B2Aug 20, 2019
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations50
US9981946B2May 29, 2018
Pyridine-substituted 2-aminopyridine protein kinase inhibitors
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1 citations50
US10155722B2Dec 18, 2018
Antitumor compound targeting IDH2 mutation and method of use thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD0 citations41